You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Novel Methods to Monitor Health Status and Clinical Laboratory Data: Portable Acquisition, Assessment, and Reporting
SBC: Mimosa Acoustics Inc. Topic: OSD09H26Mimosa Acoustics will develop a portable binaural audiological device, based on our successful HearID system. HearID is a clinical system for otoacoustic emission and middle-ear power analysis testing; it is FDA and CE-marked. The new system will have the ability to conduct a variety of audiological tests especially for use in hearing-conservation programs, including: flexible otoacoustic emission ...
SBIR Phase II 2011 Department of DefenseDefense Health Agency -
Evidence-Based Evaluation Process for Traumatic Brain Injuries and Co-morbid Psychological Disorders in Service Members
SBC: JXT Applications, Inc. Topic: OSD09H07Mild traumatic brain injury (mTBI) is associated with emotional and physical health problems, of which PTSD and depression are important mediators. Our Phase I research created a conceptual model for a user-friendly, empirically-based screening/tracking tool available to first responders and medical practitioners to screen for mTBI or other disorders. We assessed the co-occurrence of these co-mo ...
SBIR Phase II 2011 Department of DefenseDefense Health Agency -
Handheld Aptamer-Magnetic Bead-Quantum Dot Sensor for Leishmania
SBC: Operational Techologies Corporation Topic: OSD09H21Operational Technologies Corporation (OpTech) has completed a successful Phase I SBIR contract in which 72 new candidate DNA aptamer sequences against Leishmania major were developed and screened by ELISA-like plate assay. Several pilot assays were developed from the highest affinity candidate aptamers using a commercially available handheld and battery-operated fluorometer. In Phase II, OpTech p ...
SBIR Phase II 2011 Department of DefenseDefense Health Agency -
Aeromedical Transport Litter Immobilization and Stabilization (ATLIS) Platform
SBC: CORNERSTONE RESEARCH GROUP INC Topic: OSD09H13Cornerstone Research Group Inc. (CRG) proposes to redefine the immobilization and evacuation of SCI and TBI patients by developing a new patient stabilization system for aeromedical transport. This system will properly immobilize patients in a variety of transport configurations and reduce dynamic flight effects. CRG"s design will decrease co-morbidity associated with improper immobilization of SC ...
SBIR Phase II 2011 Department of DefenseDefense Health Agency -
MedWorld Medical Gaming Suite
SBC: Critical Mass Interactive, Inc. Topic: OSD10H08MedWorld will apply virtual world gaming techniques to enable military medical personnel to experience the impact of real world conditions in performance of their duties, whether they are on the battlefield or in a stateside hospital. MedWorld is struc
SBIR Phase I 2011 Department of DefenseDefense Health Agency -
Deployable Closed-Loop Anesthesia System
SBC: NEUROWAVE SYSTEMS INC Topic: OSD10H05This proposal will address the needs described in sub-topic OSD10-H05 ("Deployable Automated Analgesia and Anesthesia System"), by developing the AutoTIVATM, a portable closed-loop anesthesia system based on non-invasive cortical monitoring. This system w
SBIR Phase I 2011 Department of DefenseDefense Health Agency -
Advanced Blood Simulant for Simulation Based Medical Trauma Training
SBC: SPECTRA GROUP LIMITED, INC. Topic: OSD10H01Several approaches to make a fully functional commercial blood simulant are proposed. The simulant will have similar flow characteristics, tactile properties, color, and coagulation capabilities to blood. In this effort, Spectra Group will formulate a p
SBIR Phase I 2011 Department of DefenseDefense Health Agency